MSG Sports is splitting the Knicks and Rangers into two stocks, and history says spin-offs tend to beat IPOs Ukraine’s drones lose their Starlink link above 100 mph. Musk, Rubio and Trump all say it wasn’t them Ukraine and the U.S. are at odds over Starshield. Here's what to know ‘How many canaries have we killed in the coal mine?’ — Wall Street debates if the latest AI bubble warnings are another head fake or the real thing Trump denies limiting Ukraine access to Starlink network Brian Sullivan: Why the 'real' price of oil is likely $30-$40 higher than where it is now Harvard’s endowment jumps 27% in fiscal 2026, lifted by SpaceX as top holding Why is Starlink internet so important on the battlefield in Ukraine? City becomes hub for booming Esports industry Bipartisan group of senators call on Trump to rescind Russian diesel deal

Zhong Huijuan

Zhong Huijuan

Zhong Huijuan (#151)

Global Rank #151
Country Rank #19
Country China

Zhong Huijuan is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 18 B
  • Pharmaceuticals
  • China
  • F
  • 65 Years

Snapshot

Quick Facts

Global Rank #151
Country Rank #19
Net Worth $18.2B
Previous Worth $18.2B
Worth Change +$0.0B
Country China
Industry Pharmaceuticals
Age 65 Years
Gender F
Worth As Of April 29, 2026
Last Refreshed 05 Sep 2026, 12:00 AM
Residence Shanghai, China
World Billionaires List China Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 65
Source Of Wealth Pharmaceuticals, Self Made
Residence Shanghai, China
Citizenship China
Marital Status Married
Children 1
Education Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing University
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $18.2B
Current Net Worth $18.2B

Worth as of April 29, 2026

About Me

Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs. Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong. Their daughter, Sun Yuan, is Hansoh's executive director. Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019. Hansoh has licensed products including weight-loss treatments to global pharmaceutical giants such as Merck in billion-dollar deals, as the firm expands internationally.

Wealth Growth

Net Worth Growth Over Time

Tracking Zhong Huijuan's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $18.2B (April 29, 2026)

© Iconic Billionaires